3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, Non-Hodgkin
10
Leukemia, Myeloid, Chronic-Phase
10
Leukemia, Lymphocytic, Chronic, B-Cell
10
Hodgkin Disease
10
Multiple Myeloma
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Follicular
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Burkitt Lymphoma
9
Blast Crisis
9
Myeloproliferative Disorders
8
Leukemia, Myelomonocytic, Chronic
8
Leukemia, Myeloid, Accelerated Phase
8
Leukemia, Hairy Cell
8
Lymphoma, T-Cell, Cutaneous
7
Congenital Abnormalities
7
Primary Myelofibrosis
6
Breast Neoplasms
6
Testicular Neoplasms
5
Sezary Syndrome
5
Pdgfra-Associated Chronic Eosinophilic Leukemia
5
Neoplasms
5
Myelodysplastic Syndromes
5
Mycosis Fungoides
5
Leukemia, Neutrophilic, Chronic
5
Interventions
AP 1903 reagent
3
ON 01910
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
cedazuridine
1
Therapeutics
1
Sertraline
1
Peripheral Blood Stem Cell Transplantation
1
Interleukin-8
1
IDO-1 inhibitor LY3381916
1
HuMax-IL8
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Exercise
1
Decitabine
1
DNA
1
Cyclophosphamide
1
Cord Blood Stem Cell Transplantation
1
Busulfan
1
Bone Marrow Transplantation
1
Biopsy
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytopenia
×
Therapeutics
×
Myeloid
×
Clear all
NCT02775383
2026-02-03
MDS
National Heart, Lung, and Blood Institute (NHLBI)
Completed
2,115 enrolled